PreComb

PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.

Total raised

€2.0M

€2,034,885

Funding rounds

Investors

distinct backers

Active since

2021-04

latest 2024-12

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood53

base rate 44% for Series A

Exit likelihood12

base rate 12% (2+ rounds)

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2024-12-30	Series A	—	—	View deal →
2021-04-27	Seed	€2.0M	FiveT Capital,High-Tech Gründerfonds,Kinled Austria	View deal →

same sector or country